Citi Assumes PTC Therapeutics (PTCT), Upgrades to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 68.54 +0.42 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.12 | 52 Week High | $35.40 | |||
| Open | $69.68 | 52 Week Low | $4.03 | |||
| Day High | $70.11 | P/E | 7.29 | |||
| Day Low | $68.50 | EPS | $9.40 | |||
| Volume | 76,678 | |||||
